Revier Therapeutics
PrivateLast Round
Seed
Aug 25, 2026
Total Funding Raised
$7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Revier Therapeutics is a biotechnology company developing disease-modifying small molecule therapies that selectively target class IIa HDACs to treat cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revier Therapeutics Comparables
Compare Revier Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brano Therapeutics | 83% | |
| Tenaya Therapeutics | 71% | |
| Fauna Bio | 70% | |
Revier Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 25, 2026 |
Revier Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHAN Technology Transfer Fund II | Seed |
| VORNvc | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
$7M round led by KHAN Technology Transfer Fund II.
Revier Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revier Therapeutics's valuation, stock price, and market status.